5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: A clinical experience

Authors

  • Lisa Podolsky Division of Hematology and Oncology, Department of Medicine
  • Melissa Oh Division of Hematology and Oncology, Department of Medicine
  • Pochi R. Subbarayan Division of Hematology and Oncology, Department of Medicine
  • Dido Francheschi Department of Surgical Oncology, Miller School of Medicine, University of Miami, Miami, Florida, USA
  • Alan Livingstone Department of Surgical Oncology, Miller School of Medicine, University of Miami, Miami, Florida, USA
  • Bach Ardalan Division of Hematology and Oncology, Department of Medicine

DOI:

https://doi.org/10.3109/0284186X.2010.524934

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2011-05-01

How to Cite

Podolsky, L., Oh, M., Subbarayan, P. R., Francheschi, D., Livingstone, A., & Ardalan, B. (2011). 5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: A clinical experience. Acta Oncologica, 50(4), 602–605. https://doi.org/10.3109/0284186X.2010.524934

Issue

Vol. 50 No. 4 (2011): Acta Oncologica

Section

Articles